Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
RNA
Sort By
Newest First
1 / 2
RNA
Enabling Cost-Effective, Rapid Access to RNA Vaccines and Therapeutics with Enzymatically Generated z- dbDNA
Lisa Caproni
Touchlight
PAO-01-25-CL-08
Feb 10, 2025
Advanced Therapies
Ensuring Nuclease Free Process Consumables for Biopharma Applications
Richard Fry
Sanisure
PAO-01-25-CL-05
Jan 22, 2025
RNA
Screening T7 Polymerases to Optimize xRNA Yield and Quality
Jing Zhu, Ph.D.
ReciBioPharm
PAO-01-25-CL-02
Jan 07, 2025
Lexogen
RNA
Lexogen launches Streamlined, Large-scale RNA-Seq Service for Blood Samples
Lexogen
PR-11-24-NI-99
Nov 15, 2024
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
ReciBioPharm
PAO-10-24-CL-13
Oct 25, 2024
Waters Corporation
Large Molecule
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
Waters Corporation
PR-10-24-NI-38
Oct 11, 2024
Biotech
Five Small Biotechs to Watch: October 2024
David Alvaro, Ph.D.
Pharma's Almanac
PR-09-24-NI-10
Sep 23, 2024
Morpholinos
Modifying RNA Splicing with Morpholinos
Jon Moulton, Ph.D.
Gene Tools
PTV-10-23-CL-01
Oct 27, 2023
CRB
Digitalization, AI, and Automation
Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds
CRB
PR-M10-23-05
Oct 19, 2023
Exothera
RNA Manufacturing
Exothera Nucleic Acids will be the World’s First CDMO with Access to Quantoom’s Revolutionary Nfinity™ Platform for the continuous production of RNA which Exothera will offer as a service.
Exothera
PR-M04-23-01
Apr 19, 2023
Combining RNA Splicing and AI Technologies to Accelerate Drug Discovery and Development
Martin Akerman, Ph.D.
Envisagenics
PAO-02-23-CL-08
Apr 12, 2023
Gene Tools
Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos
David Alvaro, Ph.D.; Jon Moulton, Ph.D.
Pharma's Almanac
PAO-01-23-CL-05
Feb 01, 2023
SCIEX
RNA Analysis Kit Launch
RNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics
SCIEX
PR-M05-22-09
May 16, 2022
Cancer Genetics
Developing RNA Screening for Cancer Diagnosis
Calviri
PAO-04-22-R250-08
Apr 05, 2022
Rare Diseases
Leveraging AI and RNA to Fight Rare Diseases
Envisagenics
PAO-02-22-R250-17
Feb 24, 2022
AstraZeneca
Collaboration
AstraZeneca to Discover and Develop Novel Therapies Targeting RNA-Modifying Proteins in Oncology Collaboration with Accent Therapeutics
AstraZeneca
PR-M06-20-NI-005
Jun 04, 2020
RNA Biomarkers
RNA Biomarkers for Early Lung Cancer Diagnosis
Ron Andrews
OncoCyte
PAP-Q1-20-CL-014
Mar 19, 2020
RNA
RNA Repressor Switches Off Protein Production
Emilie Branch
Pharma's Almanac
PAO-M11-19-NI-001
Nov 06, 2019
Moderna
Positive Results
Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)
Moderna
PR-M09-19-NI-039
Sep 16, 2019
Drug Development
Arrakis Therapeutics Developing Oral Drugs that Target RNA
Nice Insight
PAO-M05-19-NI-008
May 02, 2019
1 / 2
